Analyst consensus rating
Cytosorbents Analyst Rating: none
Direct answer
Cytosorbents's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $47.50.
Forecast evidence checked October 17, 2026.
Get free Cytosorbents email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.11
- Average price target
- $47.50
- High price target
- $80.00
- Low price target
- $15.00
- Low target gap
- +265%
- Target upside
- +1,055.7%
- High target gap
- +1,846.5%
- Target range width
- 1,581.5%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cytosorbents?
Cytosorbents has a verified none consensus. The same dataset has an average price target of $47.50.
How far are Cytosorbents's low and high targets from the recorded price?
The low target implies +265%, while the high target implies +1,846.5%.
How many analysts are included in Cytosorbents's consensus?
The verified consensus includes 2 analysts.
How is Cytosorbents's target upside or downside calculated?
The average target of $47.50 is divided by the recorded price of $4.11, then one is subtracted to produce +1,055.7%. This does not guarantee a future return.
When was Cytosorbents's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.